|
Infliximab improved psoriasis by 75% in nearly 90% of patients. (Study of 249 Patients).
Publication: Skin & Allergy News Publication Date: 01-JUN-03 Author: Bates, Betsy
|
|
|
|
How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.
|
|
|
COPYRIGHT 2003 International Medical News Group
SAN FRANCISCO -- Almost 90% of psoriasis patients receiving three doses of infliximab achieved a 75% improvement in the extent and severity of their psoriasis in the largest-scale study of the intravenous biologic therapy to date, it was announced at the annual meeting of the American Academy of Dermatology.
The 10-week results of the 249-patient SPIRIT trial surpass those of any biologic therapy studied in a large group of patients with psoriasis.
The investigators, led by Dr. Alice Gottlieb, randomized patients with moderate to severe psoriasis to receive 3-mg/kg or 5-mg/kg infusions...
Read the full article for free courtesy of your local library.
|
|
|
|
 |
| More Articles from Skin & Allergy News |
HHS Inspector General faults drug review process. (Attention to Worklo...
June 01, 2003
|
Survey: states' nail industry regs fall short as litigation increases....
June 01, 2003
|
U.S. sun exposure behavior worsened during 1996-2003. (More Tanning, L...
June 01, 2003
|
Smallpox vaccine given to 103 pregnant women. (Fetal Vaccinia Extremel...
June 01, 2003
|
Drug update: oral agents for type 2 diabetes. (Clinical Rounds).
June 01, 2003
|
|
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
